DOGCULTR

About the Trial

Please read the following information before proceeding.

What are these chews?

These chews are designed to support regulation, not sedation. They are for dogs who struggle to settle, or get stuck in patterns they cannot move through. This is not about making your dog easier to live with. This is about helping your dog process instead of react.

The soft chew combines:

  • Lion's Mane for learning, memory, and brain support
  • Reishi to help the nervous system settle
  • Turkey Tail to strengthen gut and immune resilience

Magnolia Bark and L-Theanine are included to take the edge off without dulling the dog. Together, these ingredients support capacity, not suppression.

What is the stack?

The stack formulation adds a lab-tested, sub-perceptual psilocybin microdose calibrated for canine metabolism.

How it works

It is below any visible effect, with no “trip” and no sedation. The thinking comes from emerging work around neuroplasticity, pointing toward reduced rigidity in fear patterns and more flexibility in how the brain responds. That said, dogs are not humans, and this space is still in its early stages. This is not a miracle and not a replacement for structure.

The goal is to support the nervous system so the dog can move out of constant reactivity. Over time, this may look like less intensity, faster recovery, and an improved ability to settle. Not because the dog is suppressed, but because the dog has more room to make different choices.

What to expect

  • No visible intoxication or altered behavior
  • Gradual reduction in anxiety symptoms over 7–14 days
  • Possible mild increase in appetite (normal)
  • Improved sleep quality and reduced restlessness

Safety

These chews have been formulated by veterinary pharmacologists and tested in preliminary safety studies. However, this is a private trial, and the product is not yet FDA-approved for veterinary use. Your participation helps us gather the observational data needed for future regulatory submissions.

If your dog is currently taking SSRIs, it should not participate in this trial.

Step 1 of 6